ARCHIVES

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

This article is from The Cancer Letter archive.

Vol. 30 No. 3 | March 30, 2007

Download PDF Visit The Full Archive

Related Articles

DCT Board Sends Letter Opposing Bill Requiring Research On RU 486

November 13, 1992

In Brief: Georgetown, Theurer Form Collaboration; Hopkins To Develop Bladder Cancer Institute

June 6, 2014

Combined analysis moves Herceptin to adjuvant setting in breast cancer.

May 27, 2005

Bushes Restate Commitment to Dialogue

August 8, 2003

NCI Programs: BSA Approves $30M 5-Year Set-Aside For Leadership Initiative On Cancer

November 20, 1998

Tri-Institutional Stem Cell Initiative Funds Grants.

August 4, 2006